TNDM | tickerfilter.com

Fundamental analysis

21%

Profitability 18%

Dept financing 25%

Liquidity 57%

Performance 15%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

1.07%

1 Month

23.17%

3 Months

-16.06%

6 Months

-8.96%

1 Year

19.24%

2 Year

-12.18%

Key data

Stock price

$37.17

P/E Ratio

-20.86

DAY RANGE

$36.60 - $37.56

EPS

-$2.09

52 WEEK RANGE

$23.23 - $53.66

52 WEEK CHANGE

$20.36

MARKET CAP

2.848 B

YIELD

N/A

SHARES OUTSTANDING

65.465 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

10/30/2024

BETA

1.47

PUBLIC FLOAT

AVERAGE 10 VOLUME

$1,442,853

AVERAGE 30 VOLUME

$1,282,987

Company detail

CEO: John F. Sheridan
Region: US
Website: tandemdiabetes.com
Employees: 2,600
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Tandem Diabetes Care, Inc. designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system. It also offers t:connect, a web-based data management application, continuous glucose monitoring, and supported blood glucose meters.

TNDM - TANDEM DIABETES CARE INC